Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-26, Stock:PFE, The news for the past five days is as follows:
2019-02-19: NEWS1: Spark Therapeutics (ONCE) Q4 2018 Earnings Conference Call Transcript.NEWS2: After Hours Most Active for Feb 19, 2019 :  SIRI, PFE, CHK, MO, VER, FDC, ZAYO, WBA, PYPL, AGNC, ADBE, SHY.NEWS3: After Hours Most Active for Feb 19, 2019 :  SIRI, PFE, CHK, MO, VER, FDC, ZAYO, WBA, PYPL, AGNC, ADBE, SHY.NEWS4: What's in Store for Sangamo (SGMO) This Earnings Season?.NEWS5: What's in Store for Sangamo (SGMO) This Earnings Season?.NEWS6: IWB, UNH, V, PFE: ETF Outflow Alert.NEWS7: IWB, UNH, V, PFE: ETF Outflow Alert.NEWS8: Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials.NEWS9: What's in Store for Sangamo (SGMO) This Earnings Season?.NEWS10: Health Care Sector Update for 02/19/2019: ICPT, MDT, NEO, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 02/19/2019: ICPT, MDT, NEO, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Pfizer Receives European Approval for ZIRABEV™ (bevacizumab), a Biosimilar to Avastin®*.NEWS13: Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster.NEWS14: Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster.NEWS15: Gliknik To Receive $15 Million Milestone Payment From Pfizer Inc. Following Clinical Progress With PF-06755347, Previously Known As GL-2045.NEWS16: Pfizer-Lilly drug shown to help reduce back pain in late-stage trial.NEWS17: Pfizer&apos;s Forgotten Cancer Pill Is About to Become Its Next Blockbuster.NEWS18: Higher dose of Pfizer-Lilly drug helps reduce back pain in study.NEWS19: Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain.
2019-02-20: NEWS1: Better Buy: Pfizer vs. Eli Lilly.NEWS2: Better Buy: Pfizer vs. Eli Lilly.NEWS3: After Hours Most Active for Feb 20, 2019 :  PFE, ET, TAHO, PRQR, TWTR, XEL, SIRI, QCOM, NWL, XOM, T, AMED.NEWS4: After Hours Most Active for Feb 20, 2019 :  PFE, ET, TAHO, PRQR, TWTR, XEL, SIRI, QCOM, NWL, XOM, T, AMED.NEWS5: Market Recap for Wednesday February 20.NEWS6: Better Buy: Pfizer vs. Eli Lilly.NEWS7: Pfizer & Lilly's Pain Candidate Succeeds in Back Pain Study.NEWS8: Pfizer & Lilly's Pain Candidate Succeeds in Back Pain Study.NEWS9: Pfizer & Lilly's Pain Candidate Succeeds in Back Pain Study.
2019-02-21: NEWS1: Health Care Sector Update for 02/21/2019: JNJ, A, TFX, PFE, MRK, AMGN, ABT.NEWS2: Health Care Sector Update for 02/21/2019: JNJ, A, TFX, PFE, MRK, AMGN, ABT.NEWS3: Fears of Amazon appear overblown as companies that fretted competition went on to beat market.NEWS4: Fears of Amazon appear overblown as companies that fretted competition went on to beat market.
2019-02-22: NEWS1: Trump nominates Kelly Craft as UN ambassador.NEWS2: After Hours Most Active for Feb 22, 2019 :  CAR, PFE, FCX, S, CSCO, V, KMI, CVET, FB, SNAP, INTC, Z.NEWS3: After Hours Most Active for Feb 22, 2019 :  CAR, PFE, FCX, S, CSCO, V, KMI, CVET, FB, SNAP, INTC, Z.NEWS4: Intel, Pfizer Lead Dow Jones Rally; 3 Stocks Explode Higher On Earnings.NEWS5: U.S. closes IV solution shortage antitrust probe, Baxter says.NEWS6: Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates.NEWS7: Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates.NEWS8: Dow Movers: WBA, INTC.NEWS9: Dow Movers: WBA, INTC.NEWS10: Pfizer executive Sally Susman to host 2020 presidential fundraiser for Democrat Kirsten Gillibrand.NEWS11: Pfizer executive Sally Susman to host 2020 presidential fundraiser for Democrat Kirsten Gillibrand.NEWS12: Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review.NEWS13: Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review.NEWS14: Health Care Sector Update for 02/22/2019: ZSAN, OBLN, OCUL, JNJ, PFE, ABT, MRK, AMGN.NEWS15: Health Care Sector Update for 02/22/2019: ZSAN, OBLN, OCUL, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 25, 2019.NEWS17: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 25, 2019.NEWS18: Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates.NEWS19: Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review.NEWS20: Icon PLC (ICLR) Q4 2018 Earnings Conference Call Transcript.NEWS21: What Pharma Investors Need to Know About Pfizer's Latest Disaster.NEWS22: What Pharma Investors Need to Know About Pfizer's Latest Disaster.NEWS23: What Pharma Investors Need to Know About Pfizer&apos;s Latest Disaster.
2019-02-25: NEWS1: Technician says it's time to fade the biotech rally.NEWS2: Pharma CEOs to face tough questions about skyrocketing drug prices.NEWS3: Factbox: Pharma company executives to testify at U.S. Senate drug price hearing.NEWS4: There will be continued interest in gene therapy, says biotech analyst.NEWS5: Drug pricing showdown: Pharma CEOs set to testify before Congress on Capitol Hill Tuesday.NEWS6: Big Pharma to testify in Senate drug pricing hearing.NEWS7: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS8: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS9: Dow’s Best-Performing Stock in 2018 Gets Vote of Confidence.NEWS10: Healthcare Stocks Leading the Sector.NEWS11: What's in the Cards for Nektar (NKTR) This Earnings Season?.NEWS12: What's in the Cards for Nektar (NKTR) This Earnings Season?.NEWS13: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS14: What's in the Cards for Nektar (NKTR) This Earnings Season?.

Answer: Decrease